The efficacy of intravitreal vancomycin and dexamethasone in the treatment of experimental Bacillus cereus endophthalmitis

Current Eye Research

Volumn 33, Issue 9, 2008, Pages 761-768

  Liu, Fang ^a   Kwok, Alvin K H ^b   Cheung, Bernard M Y ^c  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b HONG KONG SANATORIUM AND HOSPITAL   (Hong Kong)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Bacillus cereus; Dexamethasone; Endophthalmitis; Intravitreal; Vancomycin

Indexed keywords

DEXAMETHASONE; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACILLUS CEREUS; CONJUNCTIVA; CONTROLLED STUDY; DISEASE MODEL; DISEASE SEVERITY; DRUG EFFICACY; ENDOPHTHALMITIS; INFLAMMATION; IRIDOCYCLITIS; IRIS; NONHUMAN; PRIORITY JOURNAL; RABBIT; RETINITIS; TREATMENT OUTCOME; VITREOUS BODY;

ANIMALS; ANTI-BACTERIAL AGENTS; BACILLUS CEREUS; CHOROID DISEASES; DEXAMETHASONE; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; ENDOPHTHALMITIS; EYE INFECTIONS, BACTERIAL; GLUCOCORTICOIDS; GRAM-POSITIVE BACTERIAL INFECTIONS; INJECTIONS; IRIDOCYCLITIS; RABBITS; TREATMENT OUTCOME; VANCOMYCIN; VASCULITIS; VITREOUS BODY;

EID: 51949098463     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.1080/02713680802344690     Document Type: Article

References (31)

1. Endophthalmitis Vitrectomy Study Group. Results of the endophthalmitis vitrectomy study: A randomized trial of immediate vitrectomy and intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthamol. 1995;113:1479-1496.
2. Jonas JB, Knorr HL, and Budde WM. Prognostic factors in ocular injuries caused by intraocular or retrobulbar foreign bodies. Ophthalmology. 2000;107:823-828.
3. Meredith TA. Posttraumatic endophthalmitis. Arch Ophthalmol. 1999;117:520-521.
4. O'Brien TP, Choi. S. Trauma-related ocular infections. Int Ophthalmol Clin N Am. 1995;8:667-679.
5. Thompson ST, Parver LM., Enger CL, Meiler WF, Liggett PE. Infectious endophthalmitis after penetrating injuries with retained intraocular foreign bodies. Ophthalmology. 1993;100:1468-1474.
6. Bannerman TL, Rhoden DL, McAllister SK, Miller JM, Wilson LA. The source of coagulase-negative staphylococci in the Endophthalmitis Vitrectomy Study: A comparison of eyelid and intraocular isolates using pulsed-field gel electrophoresis. Arch Ophthalmol. 1997;115:357-361.
7. Durum SK, Oppenheim JJ. Proinflammatory cytokines and immunity. In: Paul WE, ed. Fundamental Immunology, 3rd ed. New York, Raven Press; 1993:801-835.
8. Vahey JB, Flynn HW Jr. Results in the management of Bacillus endophthalmitis. Ophthalmic Surg. 1991;22:681-686.
9. Davey RT, Tauber WB. Posttraumatic endophthalmitis: The emerging role of Bacillus cereus infection. Rev Infect Dis. 1987;9:110-123.
10. Lesk MR, Ammann H, Marcil G, Vinet B, Lamer L, Sebag M. The penetration of oral ciprofloxacin into the aqueous humor, vitreous, and subretinal fluid of humans.Am J Ophthalmol. 1993;115:623-628.
11. Aguilar HE, Meredith TA, Drews C, Grossniklaus H, Sawant AD, Gardner S. Comparative treatment of experimental Staphylococcus aureus endophthalmitis. Am J Ophthalmol. 1996;121:310-317.
12. Park SS, Samiy N, Ruoff K, D'Amico DJ, Baker AS. Effect of intravitreal dexamethasone in treatment of pneumococcal endophthalmitis in rabbits. Arch Ophthalmol. 1995;13:1324-1329.
13. Jett BD, Jensen HG, Atkuri RV, Gilmore MS. Evaluation of therapeutic measures for treating endophthalmitis caused by isogenic toxin-producing and toxin-nonproducing Enterococcus faecalis strains. Invest Ophthalmol Vis Sci. 1995;36:9-15.
14. Alfaro DV, Davis J, Kim S, Bia F, Bogard JF, Briggs JW, Liggett PE. Experimental Bacillus cereus post-traumatic endophthalmitis and treatment with ciprofloxacin. Br J Ophthalmol. 1996;80:755-758.
15. Meredith TA, Aguilar HE, Miller MJ, Gardner SK, Trabelsi A, Wilson LA. Comparative treatment of experimental Staphylococcus epidemidis endophthalmitis. Arch Ophthalmol. 1990:108:857-860.
16. Coats ML, Peyman GA. Intravitreal corticosteroids in the treatment of exogenous fungal endophthalmitis. Retina. 1992;12:46-51.
17. Park SS, Vallar RV, Hong CH, von Gunten S, Ruoff K, D'Amico DJ. Intravitreal dexamethasone effect on intravitreal vancomycin elimination in endophthalmitis. Arch Ophthalmol. 1999;117:1058-1062.
18. Park SS, Samiy N, Ruoff K, D'Amico DJ, Baker AS. Effect of intravitreal dexamethasone in treatment of pneumococcal endophthalmitis in rabbits. Arch Ophthalmol. 1995;113:1324-1329.
19. Pollack JS, Beecher DJ, Pulido JS, Lee Wong AC. Failure of intravitreal dexamethasone to diminish inflammation or retinal toxicity in an experimental model of Bacillus cereus endophthalmitis. Curr Eye Res. 2004;29:253-259.
20. Liu SM, Way T, Rodrigues M, Steidl SM. Effects of intravitreal corticosteroids in the treatment of Bacillus cereus endophthalmitis. Arch Ophthalmol. 2000;118:803-806.
21. Yoshizumi, MO, GC Lee, RA Equi, IT Kim, Pitchekian-Halabi H, Adamu SA, Mondino BJ. Timing of dexamethasone treatment in experimental Staphylococcus aureus endophthalmitis. Retina. 1998;18:130-135.
22. Shah GK, Stein J D, Sharma S, Sivalingam A, Benson WE, Regillo CD, Brown GC, Tasman W. Visual outcomes following the use of intravitreal steroids in the treatment of postoperative endophthalmitis. Ophthalmology. 2000;107:486-489.
23. Das T, Jalali S, Gothwal VK, et al. Intravitreal dexamethasone in exogenous bacterial endophthalmitis: Results of a prospective random study. Br J Ophthalmol. 1999;83:1050-1055.
24. Peyman GA, Pagur JT, Meisels HI, Bennett TO. Postoperative endophthalmitis: A comparison of methods for treatment and prophylaxis with gentamicin. Ophthalmic Surg. 1975;6:45-55.
25. Callegan MC, Booth MC, Jet BD, Gilmore MS. Pathogenesis of Gram-positive bacterial endophthalmitis. Infect Immun. 1999;67:3348-3355.
26. Beecher DJ, Olsen TW, Somers EB, Wong ACL. Evidence for contribution of tripartite hemolysin BL, phosphatidylcholine-preferring phospholipase C, and collagenase to virulence of Bacillus cereus endophthalmitis. Infect Immun. 2000;68:5269-5276.
27. Beecher DJ, Pulido JS, Barney NP, Wong ACL. Extracellular virulence factors in Bacillus cereus endophthalmitis: Methods and implication of involvement of hemolysin BL. Infect Immun. 1995;63:632-639.
28. Das T, Dogra MR, Gopal LJ, et al. Postsurgical endophthalmitis: Diagnosis and management. Ind J Ophthalmol. 1995;43:103-116.
29. Alfaro DV 3rd, Hudson SJ, Offele JJ, Bevin AA, Mines M, Laughlin RM, Schoderbek RJ. Experimental posttraumatic Bacillus cereus endophthalmitis in a swine model. Efficacy of intravitreal ciprofloxacin, vancomycin, and imipenem. Retina. 1996;16:317-323.
30. Meredith TA, Aguilar E, Miller MJ, et al. Comparative treatment of experimental Staphylococcus epidermidis endophthalmitis. Arch Ophthalmol. 1990;108:857-860.
31. Meredith TA, Aguilar HE, Drews C, Sawant A, Gardner S, Wilson LA, Grossniklaus HE. Intraocular dexamethasone produces a harmful effect on treatment of experimental Staphylococcus aureus endophthalmitis. Trans Am Ophthalmol Soc. 1996;94:241-252.